iTeos Therapeutics Statistics
Total Valuation
ITOS has a market cap or net worth of $270.72 million. The enterprise value is -$212.47 million.
Important Dates
The next estimated earnings date is Wednesday, March 5, 2025, before market open.
| Earnings Date | Mar 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ITOS has 36.53 million shares outstanding. The number of shares has increased by 8.15% in one year.
| Current Share Class | 36.53M |
| Shares Outstanding | 36.53M |
| Shares Change (YoY) | +8.15% |
| Shares Change (QoQ) | +8.66% |
| Owned by Insiders (%) | 0.38% |
| Owned by Institutions (%) | 70.47% |
| Float | 27.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.18 |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.80, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.80 |
| Quick Ratio | 14.44 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -19.72% and return on invested capital (ROIC) is -14.71%.
| Return on Equity (ROE) | -19.72% |
| Return on Assets (ROA) | -13.04% |
| Return on Invested Capital (ROIC) | -14.71% |
| Return on Capital Employed (ROCE) | -21.29% |
| Revenue Per Employee | $222,930 |
| Profits Per Employee | -$772,312 |
| Employee Count | 157 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ITOS has paid $9.08 million in taxes.
| Income Tax | 9.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.92% in the last 52 weeks. The beta is 1.38, so ITOS's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -27.92% |
| 50-Day Moving Average | 7.64 |
| 200-Day Moving Average | 11.99 |
| Relative Strength Index (RSI) | 45.46 |
| Average Volume (20 Days) | 205,122 |
Short Selling Information
The latest short interest is 1.41 million, so 3.85% of the outstanding shares have been sold short.
| Short Interest | 1.41M |
| Short Previous Month | 1.34M |
| Short % of Shares Out | 3.85% |
| Short % of Float | 5.11% |
| Short Ratio (days to cover) | 4.48 |
Income Statement
In the last 12 months, ITOS had revenue of $35.00 million and -$121.25 million in losses. Loss per share was -$3.14.
| Revenue | 35.00M |
| Gross Profit | 35.00M |
| Operating Income | -146.09M |
| Pretax Income | -102.48M |
| Net Income | -121.25M |
| EBITDA | -144.95M |
| EBIT | -146.09M |
| Loss Per Share | -$3.14 |
Full Income StatementBalance Sheet
The company has $488.71 million in cash and $5.53 million in debt, giving a net cash position of $483.18 million or $13.23 per share.
| Cash & Cash Equivalents | 488.71M |
| Total Debt | 5.53M |
| Net Cash | 483.18M |
| Net Cash Per Share | $13.23 |
| Equity (Book Value) | 631.69M |
| Book Value Per Share | 17.29 |
| Working Capital | 508.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$117.44 million and capital expenditures -$2.88 million, giving a free cash flow of -$120.32 million.
| Operating Cash Flow | -117.44M |
| Capital Expenditures | -2.88M |
| Free Cash Flow | -120.32M |
| FCF Per Share | -$3.29 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -417.41% |
| Pretax Margin | -320.49% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ITOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.15% |
| Shareholder Yield | -8.15% |
| Earnings Yield | -44.79% |
| FCF Yield | -44.45% |
Analyst Forecast
The average price target for ITOS is $21.33, which is 187.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.33 |
| Price Target Difference | 187.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 53.81% |
| EPS Growth Forecast (5Y) | -16.59% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ITOS has an Altman Z-Score of 3.31 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.31 |
| Piotroski F-Score | 1 |